跳转至内容
Merck
CN
所有图片(1)

文件

CBL481

Millipore

Anti-Integrin β1 Antibody, clone TDM29

clone TDM29, Chemicon®, from mouse

别名:

CD29, platelet GPIIa, VLA beta1-chain, fibronectin receptor beta chain

登录查看公司和协议定价


About This Item

UNSPSC代码:
12352203
eCl@ss:
32160702
NACRES:
NA.41

生物来源

mouse

质量水平

抗体形式

purified immunoglobulin

抗体产品类型

primary antibodies

克隆

TDM29, monoclonal

种属反应性

human

制造商/商品名称

Chemicon®

技术

flow cytometry: suitable
immunofluorescence: suitable
immunoprecipitation (IP): suitable

同位素/亚型

IgG1

UniProt登记号

运输

wet ice

靶向翻译后修饰

unmodified

基因信息

human ... ITGB1(3688)

特异性

The antibody reacts with the integrin beta1 chain which is a membrane glycoprotein (130 kDa) that can complex with the 6 different alpha-chains of the VLA′s. It is also known as VLA beta1-chain and the fibronectin receptor. The antigen is not expressed on erythrocytes and only weakly stains granulocytes.

Antigen distribution:
T cells: 40 ± 10%
CD4+ cells: 40 ± 20%
CD8+ cells: 40 ± 15%
B cells: 20 ± 5%

免疫原

U937 cells

应用

Anti-Integrin β1 Antibody, clone TDM29 is an antibody against Integrin β1 for use in FC, IF & IP.
Research Category
Cell Structure
Research Sub Category
Integrins

外形

Format: Purified
Immunoglobulin purified by Protein A affinity chromatography and presented in PBS containing 1mg/mL BSA and 10mM sodium azide

储存及稳定性

Maintain at 2°-8°C for up to 12 months from date of receipt.

法律信息

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

免责声明

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our 产品选型工具.

WGK

WGK 2

闪点(°F)

Not applicable

闪点(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Feikun Yang et al.
Stem cell research, 39, 101489-101489 (2019-07-06)
Cell-based therapeutic strategies afford major potential advantages in the repair of injured tendons. Generation of induced pluripotent stem cells (iPSCs) expands cell sources for "regenerative" therapy. However, its application in tendon repair is still limited and the effects remain unclear.
Melissa M Ledet et al.
Scientific reports, 10(1), 20580-20580 (2020-11-27)
Determining mechanisms that naturally protect species from developing cancer is critical in order to prevent and treat cancer. Here, we describe a novel cancer-suppressing mechanism, via the secretion of bioactive factors by mammary cells, that is present in domesticated mammals
Triantafyllos Chavakis et al.
Blood, 105(3), 1036-1043 (2004-09-24)
Angiogenesis and inflammation are closely related biologic processes in wound healing and the responses to vascular injury as well as in cardiovascular diseases; however, the molecular connections are poorly defined. In particular, it is yet unclear whether endogenous factors can
Nikola Danev et al.
iScience, 27(2), 108886-108886 (2024-02-06)
Mesenchymal stromal cells (MSCs) have the potential to be used as therapeutics, but their efficacy varies due to cellular heterogeneity, which is not fully understood. After characterizing donor-matched bovine MSC from adipose tissue (AT), bone marrow (BM), and peripheral blood
Ralf Kaiser et al.
Journal of cellular and molecular medicine, 16(10), 2387-2393 (2012-02-23)
Homing of endothelial progenitor cells (EPCs) is crucial for neoangiogenesis, which might be negatively affected by hypoxia. We investigated the influence of hypoxia on fibronectin binding integrins for migration and cell-matrix-adhesion. AMP-activated kinase (AMPK) and integrin-linked kinase (ILK) were examined

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门